drugset / Trial / NCT05986292
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
RandomizedParallel-groupDouble-blindScreening
Summary
The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.
Timeline
- Start
- 2020-01-30
- Primary completion
- 2027-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fepixnebart | Monoclonal antibody | — | Intravenous |
| Subject | LY3526318 | Unknown | — | Oral |
| Subject | LY3556050 | Unknown | — | Oral |
| Subject | LY3857210 | Unknown | — | Oral |